Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Exhausted ROS Accumulation and Attenuated Pyroptosis of Nucleus Pulposus Cells via Injectable Hydrogel for Ameliorating Intervertebral Disc Degeneration.

Created on 17 Nov 2026

Authors

Wantao Wang, Yuyang Yu, Lei Liu, Lei Zhao, Shiyi Chen, Huijun Ye, Chunhong Cui, Zhaomin Zheng, Hongmei Liu, Decheng Wu

Published in

Macromolecular rapid communications. Nov 17, 2026. Epub Nov 17, 2026.

Abstract

Intervertebral disc degeneration is one of the primary contributors to chronic low back pain, yet effective therapies remain limited owing to the persistent oxidative stress and inflammatory microenvironment within the nucleus pulposus. Excessive reactive oxygen species (ROS) accumulation activates pyroptosis and amplifies inflammatory cascades, thereby accelerating disc degeneration. Herein, an injectable reactive oxygen species-responsive hydrogel (GCTD) is developed to simultaneously scavenge ROS and suppress pyroptosis for nucleus pulposus microenvironment remodeling and intervertebral disc degeneration treatment. The hydrogel is constructed by incorporating cyclodextrin-modified gelatin methacryloyl for effective delivery of disulfiram, a potent pyroptosis inhibitor, together with scavenging-ROS thioketal crosslinkers. In situ injection of GCTD into degenerated rat intervertebral discs retains disc height and maintains the structural integrity of nucleus pulposus tissue. These findings may provide a new therapy for intervertebral disc degeneration to remodel the inflammatory microenvironment of the nucleus pulposus.

PMID:
43041176
Bibliographic data and abstract were imported from PubMed on 17 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement